NEW YORK (WABC) -- Numbers were drawn in Saturday's $1.8 billion Powerball jackpot. Saturday's Powerball jackpot ranked as the second-largest jackpot in U.S. lottery history, only behind the world ...

Tonight’s Powerball drawing will soon reveal who won the second-highest jackpot in the game’s history. Going into Monday’s drawing, the jackpot sits at an estimated $1.1 billion. The cash option for ...

COVID-19 appears to be making a gradual return in California. What was once a global crisis that halted daily life is now becoming a growing concern once again in the state. The US Food and Drug ...

According to Sacnilk, after maintaining a pace by making over Rs 7 crore since its first Monday (day 5), the movie on Thursday witnessed some growth. Early estimates show that the film collected Rs 8 ...

aDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan bInternational Research Center for Infectious ...

Covid-19 is once again making headlines more than five years after the initial outbreak, with a new variant spreading in the UK and several countries across the globe. The new strain, named NB.1.8.1 ...

TOKYO, June 11 (Reuters) - Nissan (7201.T), opens new tab supplier Marelli Corp filed for Chapter 11 bankruptcy protection in the United States on Wednesday, the Japanese auto parts company said in a ...

1.1The Major Projects Report (MPR) is prepared jointly by the Department of Defence (Defence) and the Australian National Audit Office (ANAO), at the request of the Parliament. This is the sixteenth ...

More than five years since COVID was declared a pandemic, we’re still facing the regular emergence of new variants of the virus, SARS-CoV-2. The latest variant on the rise is LP.8.1. It’s increasing ...

The majority of Americans believe they need $1.8M to retire comfortably, according to the 2024 401(k) Participant Study by Charles Schwab. While that's unchanged from 2023, it is up from $1.7M in 2022 ...

First-in-human phase I trial of the oral first-in-class ubiquitin specific peptidase 1 (USP1) inhibitor KSQ-4279 (KSQi), given as single agent (SA) and in combination with olaparib (OLA) or ...

1 University Sheffield, Division of Clinical Medicine, Sheffield, United Kingdom 2 Weston Park Cancer Centre, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, Sheffield, ...